All data are based on the daily closing price as of April 30, 2026
p

Peptron

087010.KQ
176.07 USD
-6.48
-3.55%

Overview

Last close
176.07 usd
Market cap
2.70B usd
52 week high
262.86 usd
52 week low
54.60 usd
Target price
23.66 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1150.1076
Price/Book Value
44.2743
Enterprise Value
4.20B usd
EV/Revenue
1102.0718
EV/EBITDA
-17.5233

Key financials

Revenue TTM
3.93M usd
Gross Profit TTM
3.02M usd
EBITDA TTM
-7.26M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
124.06M usd
Net debt
17.12M usd

About

Peptron, Inc. engages in the development of peptide-based medicines. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, premenopausal breast cancer, and puberty; SR-Octreotide for the treatment of acromegaly; SR-Exenatide to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
  • Symbol
    087010.KQ
  • Exchange
    KQ
  • Isin
    KR7087010005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology & Medical Research
  • CEO
    Mr. Ho-Il Choi
  • Headquarter
    Daejeon
  • Web site
    http://www.peptron.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top